Madrigal Pharmaceuticals Inc. (MDGL) |
|
87.88 1.46 (1.69%)
|
10-21 16:00 |
|
Open: |
87.53 |
Pre. Close: |
86.42 |
|
High:
|
88.3292 |
Low:
|
85.39 |
|
Volume:
|
95,544 |
Market Cap:
|
1333M |
|
|
|
|
Madrigal Pharmaceuticals Inc is a company focused on the development of novel compounds for the treatment of cardiovascular-metabolic diseases and nonalcoholic steatohepatitis (NASH). |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
88.412 - 88.841 |
88.841 - 89.211 |
|
Low:
|
84.376 - 84.865 |
84.865 - 85.288 |
|
Close:
|
87.136 - 87.906 |
87.906 - 88.572 |
|
Technical analysis |
as of: 2019-10-21 4:37:22 PM |
|
Overall:
|
  |
| Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected. |
| Target: |
Six months: 110.35 One year: 119.14 |
| Support: |
Support1: 82.31 Support2: 68.48 |
| Resistance: |
Resistance1: 94.48 Resistance2: 102.00 |
| Pivot: |
86.86 |
| Moving Average: |
MA(5): 87.22 MA(20): 87.12 
MA(100): 93.91 MA(250): 112.75 |
| MACD: |
MACD(12,26): -1.60 Signal(9): -1.89 |
| Stochastic oscillator: |
%K(14,3): 55.74 %D(3): 52.33 |
| RSI: |
RSI(14): 47.59 |
| 52-week: |
High: 219.61 Low: 82.31 Change(%): -55.5 |
| Average Vol(K): |
3-Month: 19404 10-Days: 11377 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.MDGL has closed below upper band by 28.3%. Bollinger Bands are 65.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to MDGL's normal range. The bands have been in this narrow range for 5 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Headline News |
2019-10-04
The Daily Biotech Pulse: Arbutus Halts Hepatitis B Study, Positive Readout For MEI Pharma's Blood Cancer Drug, Ovid Offering
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week lows on Oct. 3) Aprea Therapeutics Inc (NASDAQ: APRE ) (IPOed on Thursday) Viela Bio Incn (NASDAQ: VIE ) (IPOed on Thursday) Down In The Dumps (Biotech stocks hitting 52-week lows on Oct. 3) Adamas Pharmaceuticals Inc (NASDAQ: ADMS ) Adaptimmune Therapeutics PLC – ADR (NASDAQ: ADAP ) Alpine Immune Sciences Inc (NASDAQ: ALPN ) bluebird bio Inc . (NASDAQ: BLUE ) Corvus Pharmaceuticals Inc (NASDAQ: CRVS ) DelMar Pharmaceuticals Inc (NASDAQ: DMP ) Eloxx Pharmaceuticals Inc (NASDAQ: ELOX ) Erytech Pharma SA (NASDAQ: ERYP ) Frequency Therapeutics Inc (NASDAQ: FREQ )(IPOed on Thursday) Fulcrum Therapeutics Inc (NASDAQ: FULC ) Jaguar Health Inc (NASDAQ: JAGX ) Karuna Therapeutics Inc (NASDAQ: KRTX ) Kiniksa Pharmaceuticals Ltd (NASDAQ: KNSA ) Madrigal Pharmaceuticals Inc (NASDAQ: MDGL ) Neuralstem, Inc. (NASDAQ: CUR ) Obseva SA (NASDAQ: OBSV ) Onconova Therapeutics Inc (NASDAQ: ONTX ) RA Medical Systems Inc (NYSE: RMED ) Sierra Oncology Inc (NASDAQ: SRRA ) Titan Pharmaceuticals, Inc. (NASDAQ: TTNP ) Trinity Biotech plc (NASDAQ: TRIB ) Viveve Medical Inc (NASDAQ: VIVE ) Stocks In Focus Arbutus Halts Hepatitis B Drug Study Arbutus Biopharma Corp (NASDAQ: ABUS ) decided to discontinue the development of AB-506, an oral capsid inhibitor, which was being evaluated in a Phase 1a/1b trial for the treatment …
2019-05-22
Madrigal, Galmed, And Galectin In Phase 3 NASH: The Need For Therapeutic Diversity
No summary available.
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
